Identity and synonyms
Catalog label is recorded; analytical identity and equivalence are not established.
Nonpeptide agent · Vitamin or precursor
Detailed molecular class: Nonpeptide agent; see mechanism for subtype
Supplied sequence or chemical reference
PubChem CID: 135398658
Molecular formula: C19H19N7O6
IUPAC: (2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
Source: PC-FOLIC-ACID
Database chemical reference; does not certify supplier vial, salt, isomer or formulation.
Mechanism
Synthetic folate form, a one-carbon-metabolism/nucleotide-synthesis nutrient.
Evidence and critical reading
Reported scientific and empirical uses
Hematologic context · Replacement and nutritional context
Neural-tube-defect prevention/deficiency correction in defined contexts; not equivalent to aesthetic blends.
Human evidence
Preventive evidence concerns periconceptional timing/specific exposure. It does not establish the same outcome for every multivitamin formulation.
Preclinical evidence
Do not equate mechanism, cell culture or animal work with a clinical outcome. The specific level is detailed in the evidence assessment.
Critical reading and limitations
Preventive evidence concerns periconceptional timing/specific exposure. It does not establish the same outcome for every multivitamin formulation.
Preventive evidence concerns periconceptional timing/specific exposure. It does not establish the same outcome for every multivitamin formulation.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Human-study exposure
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Empirical handbook
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Regulation and safety
Jurisdiction-specific regulatory context
This record does not verify FDA/EMA authorization of the commercial identity. Where a specific medicine/product exists, jurisdiction/indication are detailed in cited sources; they do not transfer to supplier material.
Adverse effects and unknowns
High amounts may correct anemia and mask B12 deficiency without resolving neurological damage. Antifolates/other medicines need contextual review.
Contraindications
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
No selected studies are attributed in this record.
Trials attributed in the package
No trials are attributed in this record.
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
Folic acid · 2735 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry queryNCT07770711 · Inositol and Metformin Administration in Mediterranean Diet and Low-Carbohydrate Diets in Women With PCOSRegistry status: RecruitingLast update posted: October 16, 2026Query verification: October 16, 2026
NCT07554521 · A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United StatesRegistry status: RecruitingLast update posted: October 16, 2026Query verification: October 16, 2026
NCT07431281 · Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2Registry status: RecruitingLast update posted: October 16, 2026Query verification: October 16, 2026
Source issues and references
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- ODS-FOLATE
October 16, 2026
- PC-FOLIC-ACID
PubChem folic acid (CID 135398658)
October 16, 2026
- SEARCH-PUBMED-folic-acid
October 16, 2026